{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:28:38Z","timestamp":1757543318925,"version":"3.37.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002627","82172605","82472640"],"award-info":[{"award-number":["82002627","82172605","82472640"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research Project of Traditional Chinese Medicine of Zhejiang Province of China","award":["GZY-ZJ-KJ-24087"],"award-info":[{"award-number":["GZY-ZJ-KJ-24087"]}]},{"name":"Basic scientific research project of Wenzhou City of China","award":["Y2023150"],"award-info":[{"award-number":["Y2023150"]}]},{"name":"National Research Center for Translational Medicine","award":["NRCTM (SH) 2019-05"],"award-info":[{"award-number":["NRCTM (SH) 2019-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-01938-9","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T06:23:16Z","timestamp":1738736596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["X-linked ubiquitin-specific peptidase 11 (USP11) increases susceptibility to Cushing\u2019s disease in women"],"prefix":"10.1186","volume":"13","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe Bao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"1938_CR1","doi-asserted-by":"crossref","unstructured":"Tritos NA, Miller KK (2023) Diagnosis and management of Pituitary adenomas: a review, vol 329. Jama, pp 1386\u20131398","DOI":"10.1001\/jama.2023.5444"},{"key":"1938_CR2","first-page":"1003","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, Giustina A, Wass JAH, Ho KKY (2022) Clin Biology Pituit Adenoma Endocr Rev 43:1003\u20131037","journal-title":"Clin Biology Pituit Adenoma Endocr Rev"},{"key":"1938_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41574-023-00868-7","volume":"19","author":"M Fleseriu","year":"2023","unstructured":"Fleseriu M, Varlamov EV, Hinojosa-Amaya JM, Langlois F, Melmed S (2023) An individualized approach to the management of cushing disease. Nat Rev Endocrinol 19:581\u2013599","journal-title":"Nat Rev Endocrinol"},{"key":"1938_CR4","doi-asserted-by":"publisher","first-page":"101521","DOI":"10.1016\/j.beem.2021.101521","volume":"35","author":"OA Hakami","year":"2021","unstructured":"Hakami OA, Ahmed S, Karavitaki N (2021) Epidemiology and mortality of Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab 35:101521","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1938_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1365-2265.1994.tb02557.x","volume":"41","author":"T Mindermann","year":"1994","unstructured":"Mindermann T, Wilson CB (1994) Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 41:359\u2013364","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1938_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1530\/EJE-13-0320","volume":"169","author":"M Yaneva","year":"2013","unstructured":"Yaneva M, Kalinov K, Zacharieva S (2013) Mortality in Cushing\u2019s syndrome: data from 386 patients from a single tertiary referral center. Eur J Endocrinol 169:621\u2013627","journal-title":"Eur J Endocrinol"},{"key":"1938_CR7","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s40618-023-02080-w","volume":"46","author":"CE Jimenez-Canizales","year":"2023","unstructured":"Jimenez-Canizales CE, Rojas W, Alonso D, Romero I, Tabares S, Veronesi Zuluaga LA, Modica R, Colao A (2023) Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia. J Endocrinol Invest 46:2275\u20132286","journal-title":"J Endocrinol Invest"},{"key":"1938_CR8","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/2020.3.FOCUS2067","volume":"48","author":"K Zhang","year":"2020","unstructured":"Zhang K, Shen M, Qiao N, Chen Z, He W, Ma Z, Shou X, Li S, Zhao Y, Pan L, Liu D, He M, Zhang Z, Li Y, Yao Z, Ye H, Wang Y (2020) Surgical outcomes and multidisciplinary management strategy of Cushing\u2019s disease: a single-center experience in China. Neurosurg Focus 48:E7","journal-title":"Neurosurg Focus"},{"key":"1938_CR9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/neuonc\/noac053","volume":"24","author":"H Yao","year":"2022","unstructured":"Yao H, Xie W, Dai Y, Liu Y, Gu W, Li J, Wu L, Xie J, Rui W, Ren B, Xue L, Cheng Y, Lin S, Li C, Tang H, Wang Y, Lou M, Zhang X, Hu R, Shang H, Huang J, Wu ZB (2022) TRIM65 determines the fate of a novel subtype of pituitary neuroendocrine tumors via ubiquitination and degradation of TPIT. Neuro Oncol 24:1286\u20131297","journal-title":"Neuro Oncol"},{"key":"1938_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma ZY, Song ZJ, Chen JH, Wang YF, Li SQ, Zhou LF, Mao Y, Li YM, Hu RG, Zhang ZY, Ye HY, Shen M, Shou XF, Li ZQ, Peng H, Wang QZ, Zhou DZ, Qin XL, Ji J, Zheng J, Chen H, Wang Y, Geng DY, Tang WJ, Fu CW, Shi ZF, Zhang YC, Ye Z, He WQ, Zhang QL, Tang QS, Xie R, Shen JW, Wen ZJ, Zhou J, Wang T, Huang S, Qiu HJ, Qiao ND, Zhang Y, Pan L, Bao WM, Liu YC, Huang CX, Shi YY, Zhao Y (2015) Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res 25:306\u2013317","journal-title":"Cell Res"},{"key":"1938_CR11","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1038\/s41467-018-05275-5","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Jian X, Deng S, Ma Z, Shou X, Shen Y, Zhang Q, Song Z, Li Z, Peng H, Peng C, Chen M, Luo C, Zhao D, Ye Z, Shen M, Zhang Y, Zhou J, Fahira A, Wang Y, Li S, Zhang Z, Ye H, Li Y, Shen J, Chen H, Tang F, Yao Z, Shi Z, Chen C, Xie L, Wang Y, Fu C, Mao Y, Zhou L, Gao D, Yan H, Zhao Y, Huang C, Shi Y (2018) Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease. Nat Commun 9:3171","journal-title":"Nat Commun"},{"key":"1938_CR12","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn PJA, Komander D (2023) Deubiquitinases in cancer. Nat Rev Cancer 23:842\u2013862","journal-title":"Nat Rev Cancer"},{"key":"1938_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41418-020-00648-0","volume":"28","author":"F Dang","year":"2021","unstructured":"Dang F, Nie L, Wei W (2021) Ubiquitin signaling in cell cycle control and tumorigenesis. Cell Death Differ 28:427\u2013438","journal-title":"Cell Death Differ"},{"key":"1938_CR14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1158\/0008-5472.CAN-22-2405","volume":"83","author":"X Zhang","year":"2023","unstructured":"Zhang X, Cheng L, Gao C, Chen J, Liao S, Zheng Y, Xu L, He J, Wang D, Fang Z, Zhang J, Yan M, Luan Y, Chen S, Chen L, Xia X, Deng C, Chen G, Li W, Liu Z, Zhou P (2023) Androgen Signaling contributes to sex differences in Cancer by inhibiting NF-\u03baB activation in T cells and suppressing Antitumor Immunity. Cancer Res 83:906\u2013921","journal-title":"Cancer Res"},{"key":"1938_CR15","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1158\/0008-5472.CAN-20-0214","volume":"80","author":"L Dwane","year":"2020","unstructured":"Dwane L, O\u2019Connor AE, Das S, Moran B, Mulrane L, Pinto-Fernandez A, Ward E, Bl\u00fcmel AM, Cavanagh BL, Mooney B, Dirac AM, Jirstr\u00f6m K, Kessler BM, T NC, Bernards R, Gallagher WM (2020) O\u2019Connor, a functional genomic screen identifies the deubiquitinase USP11 as a Novel Transcriptional Regulator of ER\u03b1 in breast Cancer. Cancer Res 80:5076\u20135088","journal-title":"Cancer Res"},{"key":"1938_CR16","doi-asserted-by":"publisher","first-page":"14866","DOI":"10.1038\/ncomms14866","volume":"8","author":"X Li","year":"2017","unstructured":"Li X, Song N, Liu L, Liu X, Ding X, Song X, Yang S, Shan L, Zhou X, Su D, Wang Y, Zhang Q, Cao C, Ma S, Yu N, Yang F, Wang Y, Yao Z, Shang Y, Shi L (2017) USP9X regulates centrosome duplication and promotes breast carcinogenesis. Nat Commun 8:14866","journal-title":"Nat Commun"},{"key":"1938_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-020-02180-4","volume":"140","author":"YT Liu","year":"2020","unstructured":"Liu YT, Liu F, Cao L, Xue L, Gu WT, Zheng YZ, Tang H, Wang Y, Yao H, Zhang Y, Xie WQ, Ren BH, Xiao ZH, Nie YJ, Hu R, Wu ZB (2020) The KBTBD6\/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. Acta Neuropathol 140:377\u2013396","journal-title":"Acta Neuropathol"},{"key":"1938_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ebiom.2019.08.061","volume":"48","author":"H Sun","year":"2019","unstructured":"Sun H, Ou B, Zhao S, Liu X, Song L, Liu X, Wang R, Peng Z (2019) USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK\/MAPK signaling pathway. EBioMedicine 48:236\u2013247","journal-title":"EBioMedicine"},{"key":"1938_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.kint.2022.11.027","volume":"103","author":"Y Shi","year":"2023","unstructured":"Shi Y, Tao M, Chen H, Ma X, Wang Y, Hu Y, Zhou X, Li J, Cui B, Qiu A, Zhuang S, Liu N (2023) Ubiquitin-specific protease 11 promotes partial epithelial-to-mesenchymal transition by deubiquitinating the epidermal growth factor receptor during kidney fibrosis. Kidney Int 103:544\u2013564","journal-title":"Kidney Int"},{"key":"1938_CR20","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, Schroeder M (2021) PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res 49:W530\u2013w534","journal-title":"Nucleic Acids Res"},{"key":"1938_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41392-024-01929-7","volume":"9","author":"Y Shi","year":"2024","unstructured":"Shi Y, Ma J, Li S, Liu C, Liu Y, Chen J, Liu N, Liu S, Huang H (2024) Sex difference in human diseases: mechanistic insights and clinical implications. Signal Transduct Target Ther 9:238","journal-title":"Signal Transduct Target Ther"},{"key":"1938_CR22","doi-asserted-by":"publisher","first-page":"6174","DOI":"10.1016\/j.cell.2021.10.022","volume":"184","author":"Y Markaki","year":"2021","unstructured":"Markaki Y, Gan Chong J, Wang Y, Jacobson EC, Luong C, Tan SYX, Jachowicz JW, Strehle M, Maestrini D, Banerjee AK, Mistry BA, Dror I, Dossin F, Sch\u00f6neberg J, Heard E, Guttman M, Chou T, Plath K (2021) Xist nucleates local protein gradients to propagate silencing across the X chromosome. Cell 184:6174\u20136192e6132","journal-title":"Cell"},{"key":"1938_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature24265","volume":"550","author":"T Tukiainen","year":"2017","unstructured":"Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, Cummings BB, Castel SE, Karczewski KJ, Aguet F, Byrnes A, Lappalainen T, Regev A, Ardlie KG, Hacohen N, MacArthur DG (2017) Landscape of X chromosome inactivation across human tissues. Nature 550:244\u2013248","journal-title":"Nature"},{"key":"1938_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41420-022-01083-5","volume":"8","author":"Y Liao","year":"2022","unstructured":"Liao Y, Zhou D, Wang P, Yang M, Jiang N (2022) Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management. Cell Death Discov 8:292","journal-title":"Cell Death Discov"},{"key":"1938_CR25","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1016\/j.cell.2022.09.002","volume":"185","author":"Y Yan","year":"2022","unstructured":"Yan Y, Wang X, Chaput D, Shin MK, Koh Y, Gan L, Pieper AA, Woo JA, Kang DE (2022) X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women. Cell 185:3913\u20133930e3919","journal-title":"Cell"},{"key":"1938_CR26","doi-asserted-by":"crossref","unstructured":"Guo Y, Cai C, Zhang B, Tan B, Tang Q, Lei Z, Qi X, Chen J, Zheng X, Zi D, Li S, Tan J (2024) Targeting USP11 regulation by a novel lithium-organic coordination compound improves neuropathologies and cognitive functions in Alzheimer transgenic mice. EMBO Mol Med","DOI":"10.1038\/s44321-024-00146-7"},{"key":"1938_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S2213-8587(18)30155-4","volume":"7","author":"RA Feelders","year":"2019","unstructured":"Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A (2019) Advances in the medical treatment of Cushing\u2019s syndrome. Lancet Diabetes Endocrinol 7:300\u2013312","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1938_CR28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1080\/13543784.2016.1254187","volume":"25","author":"AJ Brahm","year":"2016","unstructured":"Brahm AJ, Hegele RA (2016) Lomitapide for the treatment of hypertriglyceridemia. Expert Opin Investig Drugs 25:1457\u20131463","journal-title":"Expert Opin Investig Drugs"},{"key":"1938_CR29","doi-asserted-by":"publisher","first-page":"e2311760","DOI":"10.1002\/adma.202311760","volume":"36","author":"M Song","year":"2024","unstructured":"Song M, Tian J, Wang L, Dong S, Fu K, Chen S, Liu C (2024) Efficient delivery of Lomitapide using hybrid membrane-coated tetrahedral DNA nanostructures for Glioblastoma Therapy. Adv Mater 36:e2311760","journal-title":"Adv Mater"},{"key":"1938_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.canlet.2021.09.010","volume":"521","author":"Q Zuo","year":"2021","unstructured":"Zuo Q, Liao L, Yao ZT, Liu YP, Wang DK, Li SJ, Yin XF, He QY, Xu WW (2021) Targeting PP2A with lomitapide suppresses colorectal tumorigenesis through the activation of AMPK\/Beclin1-mediated autophagy. Cancer Lett 521:281\u2013293","journal-title":"Cancer Lett"},{"key":"1938_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41419-022-05039-6","volume":"13","author":"B Lee","year":"2022","unstructured":"Lee B, Park SJ, Lee S, Lee J, Lee E, Yoo ES, Chung WS, Sohn JW, Oh BC, Kim S (2022) Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR. Cell Death Dis 13:603","journal-title":"Cell Death Dis"},{"key":"1938_CR32","doi-asserted-by":"crossref","unstructured":"Fioravanti M, Flicker L (2001) Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment, Cochrane Database Syst Rev, (2001) Cd003159","DOI":"10.1002\/14651858.CD003159"},{"key":"1938_CR33","first-page":"7293","volume":"17","author":"G Zang","year":"2018","unstructured":"Zang G, Fang L, Chen L, Wang C (2018) Ameliorative effect of nicergoline on cognitive function through the PI3K\/AKT signaling pathway in mouse models of Alzheimer\u2019s disease. Mol Med Rep 17:7293\u20137300","journal-title":"Mol Med Rep"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-01938-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-01938-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-01938-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T06:23:30Z","timestamp":1738736610000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-01938-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1938"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-01938-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Samples of pituitary adenomas (PAs) were obtained from patients undergoing surgical procedures at Ruijin Hospital between 2016 and 2023. The study received ethical approval from the Ethical Review Board of Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine (China; 2019-39). The Ethical Review Board at Shanghai Jiao Tong University School of Medicine\u2019s Ruijin Hospital approved of the study\u2019s animal experimentation (China; RJ2023009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}